{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:04:14Z","timestamp":1792623854270,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010154","name":"Fundaci\u00f3n P\u00fablica Andaluza para la Gesti\u00f3n de la Investigaci\u00f3n en Salud de Sevilla","doi-asserted-by":"publisher","award":["PI-0697-2012"],"award-info":[{"award-number":["PI-0697-2012"]}],"id":[{"id":"10.13039\/100010154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40268-020-00332-1","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T19:02:36Z","timestamp":1608836556000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of Preoperative Infusion of Levosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial"],"prefix":"10.1007","volume":"21","author":[{"given":"Ana","family":"Abril-Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3366-3479","authenticated-orcid":false,"given":"Jose M.","family":"G\u00f3mez-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Esteban-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ferreiro-Marzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fernandez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Ocete-Hita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,24]]},"reference":[{"key":"332_CR1","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/01.CIR.0000051365.81920.28","volume":"107","author":"TM Hoffman","year":"2003","unstructured":"Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107:996\u20131002.","journal-title":"Circulation"},{"key":"332_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00246-017-1718-2","volume":"39","author":"V Amiet","year":"2018","unstructured":"Amiet V, Perez MH, Longchamp D, Boulos-Ksontini T, Natter J, Plaza-Wuthrich A, et al. Use of levosimendan in postoperative setting after surgical repair of congenital heart disease in children. Pediatr Cardiol. 2018;39:19\u201325.","journal-title":"Pediatr Cardiol."},{"key":"332_CR3","first-page":"CD009669","volume":"1","author":"J Schumann","year":"2018","unstructured":"Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele A, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Datab Syst Rev. 2018;1:CD009669.","journal-title":"Cochrane Datab Syst Rev"},{"issue":"4","key":"332_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.medin.2012.02.007","volume":"36","author":"JL P\u00e9rez Vela","year":"2012","unstructured":"P\u00e9rez Vela JL, Mart\u00edn Ben\u00edtez JC, Carrasco Gonz\u00e1lez M, de la Cal L\u00f3pez MA, Hinojosa P\u00e9rez R, Sagredo Meneses V, et al. Clinical practice guide for the management of low cardiac output syndrome in the postoperative period of heart surgery. Med Intensiva. 2012;36(4):e1\u201344.","journal-title":"Med Intensiva."},{"issue":"1","key":"332_CR5","first-page":"CD010947","volume":"1","author":"Y Yu","year":"2018","unstructured":"Yu Y, Zhang K, Zhang L, Zong H, Meng L, Han R. Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. Cochrane Database Syst Rev. 2018;1(1):CD010947.","journal-title":"Cochrane Database Syst Rev."},{"key":"332_CR6","first-page":"CD009515","volume":"3","author":"B Burkhardt","year":"2015","unstructured":"Burkhardt B, R\u00fccker G, Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease (Review). Cochrane Datab Syst Rev. 2015;3:CD009515.","journal-title":"Cochrane Datab Syst Rev"},{"issue":"1","key":"332_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/PCC.0b013e3181e2a437","volume":"12","author":"LM Ryerson","year":"2011","unstructured":"Ryerson LM, Alexander PM, Butt WW, Shann FA, Penny DJ, Shekerdemian L. Rotating inotrope therapy in a pediatric population with decompensated heart failure. Pediatr Crit Care Med. 2011;12(1):57\u201360.","journal-title":"Pediatr Crit Care Med."},{"issue":"1","key":"332_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00101-006-1108-2","volume":"56","author":"S Rehberg","year":"2007","unstructured":"Rehberg S, Ertmer C, Van Aken H, Lange M, Br\u00f6king K, Morelli A, et al. Role of Levosimendan in intensive care treatment of myocardial insufficiency. Anaesthesist. 2007;56(1):30\u201343.","journal-title":"Anaesthesist."},{"issue":"4","key":"332_CR9","first-page":"227","volume":"5","author":"MS Nieminen","year":"2013","unstructured":"Nieminen MS, Fruhwald S, Heunks LM, Suominen PK, Gordon AC, Kivikko M, et al. Levosimendan: current data, clinical use and future development. Heart Lung Vessel. 2013;5(4):227\u201345.","journal-title":"Heart Lung Vessel."},{"issue":"2","key":"332_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.arcped.2017.12.003","volume":"25","author":"I Goyer","year":"2018","unstructured":"Goyer I, Brossier D, Toledano B. Hemodynamic support of a 15-year-old waiting for a heart transplant: Is there a role for levosimendan in pediatric heart failure? Archives de Pediatr. 2018;25(2):132\u20135.","journal-title":"Archives de Pediatr."},{"issue":"1","key":"332_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00000539-200001000-00003","volume":"90","author":"JR Kersten","year":"2000","unstructured":"Kersten JR, Montgomery MW, Pagel PS, et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg. 2000;90(1):5\u201311.","journal-title":"Anesth Analg."},{"issue":"21","key":"332_CR12","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1616325","volume":"376","author":"G Landoni","year":"2017","unstructured":"Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, et al. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. 2017;376(21):2021\u201331.","journal-title":"N Engl J Med."},{"issue":"12","key":"332_CR13","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.jacc.2004.02.052","volume":"43","author":"S Sonntag","year":"2004","unstructured":"Sonntag S, Sundberg S, Lehtonen LA, Kleber FX. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol. 2004;43(12):2177\u201382.","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"332_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1025331617233","volume":"17","author":"J Pataricza","year":"2003","unstructured":"Pataricza J, Krass\u00f3i I, H\u00f6hn J, Kun A, Papp JG. Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery. Cardiovasc Drugs Ther. 2003;17(2):115\u201321.","journal-title":"Cardiovasc Drugs Ther."},{"issue":"6A","key":"332_CR15","doi-asserted-by":"publisher","first-page":"26G","DOI":"10.1016\/j.amjcard.2005.07.018","volume":"96","author":"M Maytin","year":"2005","unstructured":"Maytin M, Colucci WS. Cardioprotection: A new paradigm in the management of acute heart failure syndromes. Am J Cardiol. 2005;96(6A):26G-31G.","journal-title":"Am J Cardiol."},{"key":"332_CR16","first-page":"CD011312","volume":"3","author":"J Hummel","year":"2017","unstructured":"Hummel J, R\u00fccker G, Stiller B. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease (Review). Cochrane Datab Syst Rev. 2017;3:CD011312.","journal-title":"Cochrane Datab Syst Rev"},{"issue":"2","key":"332_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/aca.ACA_178_17","volume":"21","author":"PM Desai","year":"2018","unstructured":"Desai PM, Sarkar MS, Umbarkar SR. Prophylactic preoperative levosimendan for off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: Single-centered randomized prospective study. Ann Cardiac Anaesth. 2018;21(2):123\u20138.","journal-title":"Ann Cardiac Anaesth."},{"key":"332_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.acvd.2015.01.012","volume":"108","author":"PE S\u00e9gu\u00e9la","year":"2015","unstructured":"S\u00e9gu\u00e9la PE, Mauriat P, Mouton JB, Tafer N, Assy J, Poncelet G, et al. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy. Exp\u00e9rience monocentrique du levosimendan dans les myocardiopathies dilat\u00e9es p\u00e9diatriques en insuffisance cardiaque terminale. Arch Cardiovasc Dis. 2015;108:347\u201355.","journal-title":"Arch Cardiovasc Dis"},{"issue":"3","key":"332_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/1995-705X.192556","volume":"17","author":"N Jayaprasad","year":"2016","unstructured":"Jayaprasad N. Heart Failure In Children. Heart Views. 2016;17(3):92\u20139.","journal-title":"Heart Views."},{"key":"332_CR20","first-page":"45","volume":"12","author":"S Parasuraman","year":"2016","unstructured":"Parasuraman S, Walker S, Loudon BL, Gollop ND, Wilson AM, Lowery C, et al. Assessment of pulmonary artery pressure by echocardiography\u2014A comprehensive review. Int J Cardiol Heart Vasc. 2016;12:45\u201351.","journal-title":"Int J Cardiol Heart Vasc."},{"issue":"3","key":"332_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1053\/j.ajkd.2015.09.015","volume":"67","author":"Z Chenghui","year":"2016","unstructured":"Chenghui Z, Gong J, Chen D, Wang W, Liu M, Liu B, et al. Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2016;67(3):408\u201316.","journal-title":"Am J Kidney Dis."},{"key":"332_CR22","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Navero JL, De la Torre-Aguilar, de la Rosa II, Gil-Campos M, G\u00f3mez-Guzman E, Merino-Cejas C, et al. Biomarcadores cardiacos en el s\u00edndrome de bajo gasto cardiaco en el postoperatorio de cirug\u00eda de cardiopat\u00edas cong\u00e9nitas en ni\u00f1os. Rev Esp Cardiol. 2017;70:267\u201374.","DOI":"10.1016\/j.recesp.2016.09.008"},{"issue":"2","key":"332_CR23","first-page":"139","volume":"107","author":"R Magliola","year":"2009","unstructured":"Magliola R, Moreno G, Vassallo JC, Landry LM, Althabe M, Balestrini M, et al. Levosimendan, a new inotropic drug: experience in children with acute heart failure. Arch Argent Pediatr. 2009;107(2):139\u201345.","journal-title":"Arch Argent Pediatr."},{"issue":"4","key":"332_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10741-014-9442-y","volume":"19","author":"PL Santaguida","year":"2014","unstructured":"Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Balion C, et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Fail Rev. 2014;19(4):453\u201370.","journal-title":"Heart Fail Rev."},{"issue":"3","key":"332_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.amjcard.2005.03.092","volume":"96","author":"JT Parissis","year":"2005","unstructured":"Parissis JT, Panou F, Farmakis D, Adamopoulos S, Filippatos G, Paraskevaidis I, et al. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure. Am J Cardiol. 2005;96(3):423\u20136.","journal-title":"Am J Cardiol."},{"issue":"7","key":"332_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00059-018-4693-3","volume":"44","author":"S Zhou","year":"2019","unstructured":"Zhou S, Zhang L, Li J. Effect of levosimendan in patients with acute decompensated heart failure: a meta-analysis. Herz. 2019;44(7):630\u20136.","journal-title":"Herz."},{"issue":"2","key":"332_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/bja\/aen367","volume":"102","author":"L Tritapepe","year":"2009","unstructured":"Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, et al. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth. 2009;102(2):198\u2013204.","journal-title":"Br J Anaesth."},{"issue":"3","key":"332_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.jvca.2010.07.004","volume":"25","author":"M Momeni","year":"2011","unstructured":"Momeni M, Rubay J, Matta A, Rennotte MT, Veyckemans F, Poncelet AJ, et al. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth. 2011;25(3):419\u201324.","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"332_CR29","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez de Palencia-Espinosa MA, C\u00e1rceles-Bar\u00f3n MD, Bl\u00e1zquez-\u00c1lvarez MJ, Arocas-Casa\u00f1 V, de la Rubia-Nieto A. Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease. Rev Esp Anestesiol Reanim. 2012;59(9):489\u201396.","DOI":"10.1016\/j.redar.2012.06.002"},{"issue":"6","key":"332_CR30","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.ejcts.2009.05.001","volume":"36","author":"SM Kolseth","year":"2009","unstructured":"Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function. Eur J Cardiothorac Surg. 2009;36(6):1024\u201330.","journal-title":"Eur J Cardiothorac Surg."},{"key":"332_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/0885066606287039","volume":"21","author":"JR Egan","year":"2006","unstructured":"Egan JR, Clarke AJ, Williams S, Cole AD, Ayer J, Jacobe S, et al. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med. 2006;21:183\u20137.","journal-title":"J Intensive Care Med."},{"key":"332_CR32","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00134-012-2564-6","volume":"38","author":"Z Ricci","year":"2012","unstructured":"Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med. 2012;38:1198\u2013204.","journal-title":"Intensive Care Med."},{"issue":"6","key":"332_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00431-008-0834-7","volume":"168","author":"WA Osthaus","year":"2009","unstructured":"Osthaus WA, Boethig D, Winterhalter A, Huber D, Goerler H, Sasse M, et al. First experiences with intraoperative Levosimendan in pediatric cardiac surgery. Eur J Pediatr. 2009;168(6):735\u201340.","journal-title":"Eur J Pediatr."}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00332-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-020-00332-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00332-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T02:56:18Z","timestamp":1724122578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-020-00332-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1007\/s40268-020-00332-1","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,24]]},"assertion":[{"value":"20 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project received funding from the Andalusian Progress and Health Foundation, Spain (2012; protocol code PI-0697-2012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support and sponsorship"}},{"value":"The authors, AA-M, JMG-L, FP, ME-M, AF-M, CF-G, and EO-H, declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by our Regional Ethics Committee (ethical committee code EudraCT 2012-005310-19): Andalusian Regional Ethics Committee, Seville, Avda, Innovaci\u00f3n, s\/n Edif, Arena 1, CP: 41020 Spain (date of approval 12.12.2012; ethics committee president Antonio Vel\u00e1zquez Mart\u00edn).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the parents before participation. Patients were enrolled at the Virgen de las Nieves University Hospital of Granada, Spain.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the design and implementation of the research, to the analysis of the results, and to the writing of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}